genia tagger: 148('restriction', 4)
('oncogenes', 3)
('alleles', 4)
('susceptibility\\.', 1)
('130', 2)
('lymphoblastoid', 4)
('human', 22)
('alternative', 2)
('line', 37)
('1', 327)
('luciferase', 40)
('lcss', 21)
('\\>', 68)
('\\?', 86)
('tt', 45)
('untranslated', 1)
('mirnas', 7)
('controls', 48)
('\\!', 4)
('lymphocytes', 4)
('allele', 199)
('non-small', 6)
('4866', 4)
('\\(', 356)
('\\)', 356)
('pfuturbo', 4)
('family', 10)
('microrna', 2)
('rna', 28)
('mgh', 12)
('lele', 203)
('boxes', 2)
('1b', 10)
('lcs6', 96)
('lcs4', 4)
('0\\.9', 14)
('lcs1', 6)
('\\~', 4)
('c\\.i\\.\\=', 1)
('nras', 12)
('lcs9', 4)
('vector', 4)
('or\\=2\\.3', 4)
('asian', 14)
('reference', 8)
('sequence', 30)
('let-7a', 10)
('related', 23)
('cloning', 8)
('genomic', 8)
('\\/italic', 34)
('rs712', 4)
('kras', 163)
('rt', 158)
('oncogene', 8)
('reporter', 28)
('sites', 11)
('cell', 56)
('3', 262)
('messenger', 1)
('3b', 4)
('pcr\\.', 4)
('complementary', 16)
('snps', 32)
('0\\.99', 2)
('genes', 19)
('fig\\.', 24)
('regulators', 2)
('members', 8)
('utr\\.', 4)
('1\\.1\\\xe2\\\x80\\\x931\\.7', 4)
('g', 1244)
('lin-28', 2)
('studied\\.', 1)
('tumor', 64)
('pcr', 30)
('american', 10)
('products', 4)
('gene', 80)
('or', 621)
('nhe', 4)
('repair', 4)
('ci', 210)
('\\=', 36)
('cancer', 154)
('let-7', 74)
('locus', 2)
('non-blood-related', 4)
('lung', 134)
('sequences', 4)
('wild-type', 30)
('table', 40)
('cells\\.', 2)
('risk', 84)
('a549', 18)
('dna', 40)
('introduction', 1)
('\xe2\x80\x9ceuropean\xe2\x80\x9d', 4)
('codons', 4)
('1a', 10)
('2', 237)
('mirna', 17)
('nsclc', 108)
('1\\.0', 18)
('\xe2\x80\x9chigh-risk\xe2\x80\x9d', 2)
('populations', 54)
('constructs', 4)
('site', 33)
('cases', 83)
('12', 30)
('target', 5)
('cells', 22)
('vs\\.', 12)
('rnas', 11)
('grey', 2)
('utrs', 2)
('utr', 82)
('elcap', 2)
('mature', 1)
('lcs6\\.', 2)
('slitrk1', 1)
('binding', 10)
('al', 703)
('ras', 222)
('subtypes', 1)
('native', 12)
('mrnas', 2)
('perkinelmer', 4)
('40', 19)
('41', 14)
('regions', 3)
('european', 14)
('lsc6', 4)
('chromosomes', 18)
('143', 2)
('tg\\+gg', 12)
('variant', 157)
('kit', 17)
('topo', 4)
('polymerase', 4)
('snp', 112)
('geographic', 12)
('0\\.5\\\xe2\\\x80\\\x931\\.9', 2)
('pack\\-years\\.', 4)
('i', 4692)
('lines', 5)
('african', 10)
('1\\.1\\\xe2\\\x80\\\x934\\.6', 7)


spacy + metamap: 566('limited', 4)
('alleles', 4)
('global', 11)
('independent study', 4)
('messenger rna', 1)
('four', 8)
('non-small cell lung cancer', 6)
('current', 6)
('asian', 14)
('edu', 12)
('primer', 24)
('primary problem', 2)
('eligible', 4)
('graph', 30)
('tt', 45)
('sequence variations', 6)
('gene-environment interaction', 4)
('tk', 4)
('tg', 12)
('chemopreventive agents', 2)
('veterans', 12)
('risk factors', 4)
('case', 118)
('pack year', 5)
('assay', 16)
('risk', 84)
('cellular', 7)
('difference', 8)
('exact', 4)
('micrornas', 1)
('condition', 12)
('entire', 12)
('school', 4)
('respiratory', 4)
('lcs1', 6)
('cause', 12)
('smoking status', 8)
('large', 10)
('control population', 4)
('biological', 4)
('target site', 1)
('cell lines', 5)
('locus', 2)
('findings', 28)
('triplicate', 2)
('fold', 7)
('second', 5)
('cost', 2)
('carcinogen', 6)
('further', 15)
('estimated', 2)
('blue', 4)
('spouses', 4)
('abi', 8)
('sum', 4)
('selected', 4)
('asia', 24)
('access', 4)
('forward primer', 4)
('3c', 4)
('new', 27)
('contrast', 2)
('cohorts', 8)
('reporter', 28)
('genotyping', 4)
('genes', 19)
('normal tissue', 9)
('let', 78)
('groups', 12)
('histological type', 4)
('change', 4)
('east asia', 2)
('healthy', 12)
('study', 74)
('larger', 4)
('oncogenesis', 2)
('controversy', 2)
('prior', 10)
('infrequently', 4)
('products', 4)
('diagnosed', 4)
('usually', 4)
('lung adenocarcinoma', 4)
('gene', 80)
('studies', 30)
('biomarkers', 1)
('fbs', 4)
('family', 10)
('africa', 12)
('poor prognosis', 5)
('names', 4)
('marker', 22)
('tumor sample', 8)
('genetic resource', 4)
('use', 57)
('dna', 40)
('scan', 4)
('two', 38)
('few', 1)
('mirna', 17)
('lung tumor resections', 4)
('panel', 2)
('gene regulation', 2)
('more', 12)
('0\\%', 18)
('females', 4)
('populations', 54)
('known', 7)
('cases', 83)
('effort', 2)
('97', 14)
('high', 23)
('ma', 182)
('cancer patient', 4)
('restriction site', 4)
('lung tumors', 2)
('papillary thyroid cancer', 1)
('example', 4)
('10\\%', 6)
('history', 22)
('control', 92)
('slitrk1', 1)
('dna primers', 4)
('december', 4)
('sample', 68)
('allele frequency', 9)
('action', 12)
('pink', 2)
('information', 8)
('discussion', 2)
('damage', 4)
('regression', 8)
('likelihood ratio', 4)
('adjacent', 14)
('significance', 8)
('product', 10)
('act', 63)
('variant', 157)
('different', 8)
('collection', 6)
('blood', 16)
('snp', 112)
('data', 32)
('types', 6)
('overexpression', 2)
('purification', 12)
('cigarettes', 4)
('non-small cell', 6)
('green', 2)
('african', 10)
('volunteers', 4)
('smoking history', 10)
('feedback', 4)
('insight', 2)
('years', 49)
('frequency', 52)
('committee', 8)
('activating', 8)
('group', 20)
('pcr', 30)
('mirna binding', 4)
('fig', 32)
('orange', 2)
('derivative', 4)
('non', 29)
('fourth', 4)
('males', 8)
('number', 2)
('data base', 4)
('one', 40)
('day', 4)
('association', 26)
('february', 4)
('name', 4)
('university', 16)
('level', 47)
('identified', 29)
('mrna', 2)
('gender', 8)
('involvement', 4)
('european', 14)
('side', 22)
('control group', 4)
('heavy', 4)
('median', 20)
('abnormal', 1)
('related', 23)
('genetic markers', 1)
('base pairs', 4)
('year', 65)
('laboratory', 4)
('penicillin', 4)
('kras', 163)
('less frequent', 8)
('increase', 51)
('participants', 4)
('investigation', 4)
('newly', 4)
('dysfunction', 1)
('evaluation', 4)
('red', 90)
('million', 2)
('regulators', 2)
('point mutation', 1)
('members', 8)
('seventy', 4)
('genotype', 12)
('interaction', 8)
('persons', 4)
('cell culture', 4)
('americas', 2)
('adjustment', 4)
('smokers', 52)
('repeats', 2)
('first', 8)
('control sample', 4)
('variables', 12)
('primary', 8)
('odds ratio', 4)
('construct', 8)
('quality', 4)
('size', 14)
('genetic cancer', 4)
('ten', 26)
('introduction', 1)
('leading', 1)
('logistic regression', 8)
('codons', 4)
('1a', 10)
('regulation', 18)
('1b', 10)
('siberia', 2)
('let-7 microrna', 1)
('nsclc', 108)
('molecular', 8)
('scans', 2)
('lipofectamine', 4)
('continuous', 4)
('small cell lung cancer', 10)
('untranslated regions', 1)
('rtpcr', 8)
('western', 2)
('chromosomes', 18)
('genomic dna', 8)
('population', 100)
('target', 5)
('isolation', 4)
('programs', 2)
('grey', 2)
('project', 2)
('patients', 90)
('future', 4)
('target gene', 3)
('descriptions', 8)
('7a', 10)
('boston', 14)
('30\\%', 4)
('ras', 222)
('need', 4)
('sample description', 4)
('current smoker', 2)
('mechanism', 8)
('note', 4)
('potential', 10)
('finding', 41)
('human population', 1)
('supplementary material', 2)
('normal', 20)
('cigarette', 12)
('eight', 12)
('significant', 17)
('segment', 4)
('resident', 4)
('paradigm', 4)
('informed consent', 4)
('later', 2)
('disease', 6)
('first step', 2)
('natural selection', 1)
('dna repair gene', 2)
('cloning vector', 4)
('geographic population', 8)
('kits', 4)
('unconditional', 8)
('hospital patients', 4)
('availability', 4)
('geography', 2)
('impact', 16)
('cell', 56)
('smoking cessation', 6)
('only', 30)
('screening', 5)
('local', 8)
('dominant', 4)
('\\<3', 4)
('public health', 4)
('overall', 4)
('single nucleotide polymorphisms', 1)
('dna polymerase', 4)
('tuberculosis', 4)
('3b', 4)
('genetic predisposition', 4)
('cardiothoracic', 4)
('numerous', 2)
('tumors', 34)
('nras', 12)
('genetic association', 4)
('common', 4)
('dna purification', 4)
('cancer risk', 24)
('europe', 16)
('bars', 2)
('set', 6)
('low frequency', 8)
('reference', 8)
('south central asia', 2)
('testing', 2)
('sex', 4)
('individual', 10)
('result', 12)
('nm', 10)
('surgery', 4)
('subject', 4)
('oncogene', 8)
('subsequent', 4)
('kit oncogene', 1)
('sites', 11)
('promega', 8)
('identification', 2)
('previous diagnosis', 4)
('approach', 4)
('lung ct', 2)
('available', 14)
('ends', 8)
('missing', 4)
('snps', 32)
('hypothesis', 14)
('extent', 4)
('molecular markers', 4)
('reaction', 2)
('sputum', 4)
('region', 3)
('expense', 2)
('expression', 49)
('pack years', 5)
('ci', 210)
('luciferase activity', 6)
('cancer', 154)
('demographic', 8)
('let-7', 74)
('codon', 4)
('mutations', 15)
('case control', 4)
('dna repair pathway', 2)
('sequences', 4)
('dependent', 14)
('table', 40)
('ct', 222)
('age groups', 4)
('healthy adult', 4)
('described', 12)
('fre', 101)
('addition', 7)
('west', 8)
('three', 4)
('strategy', 2)
('genetic', 24)
('fluctuation', 2)
('life', 4)
('retrospective', 4)
('24 hours', 4)
('representative', 2)
('smoking', 64)
('evidence', 3)
('applied', 4)
('stage i', 4)
('caucasians', 4)
('frozen', 8)
('pgl3', 8)
('ongoing', 8)
('unreported', 4)
('error', 2)
('loop', 4)
('pack', 47)
('seven', 8)
('ct scans', 2)
('induced', 4)
('prevalence', 8)
('almost', 4)
('cell growth', 4)
('binding', 10)
('site', 33)
('very low', 2)
('tissue', 47)
('statistical analysis', 4)
('dual', 14)
('lymphoblastoid cell line', 4)
('ethnicity', 4)
('lcs', 137)
('cohort', 36)
('confirmed', 4)
('immunosuppression', 4)
('descent', 4)
('longitudinal studies', 4)
('same', 12)
('chest x-ray', 2)
('several', 5)
('higher', 13)
('independent', 6)
('in vivo', 5)
('http', 8)
('effect', 12)
('kit', 17)
('cessation', 6)
('levels', 39)
('i-', 8)
('purpose', 2)
('meta-analysis', 2)
('recent', 10)
('lower', 22)
('confidence intervals', 4)
('database', 8)
('smoker', 58)
('analysis', 26)
('person', 8)
('squamous', 4)
('model', 12)
('streptomycin', 4)
('epidemiological study', 4)
('less', 20)
('adjusted', 12)
('stored', 4)
('human', 22)
('study population', 12)
('alternative', 2)
('luciferase', 40)
('mirnas', 7)
('location', 6)
('lymphocytes', 4)
('allele', 199)
('extensive', 4)
('transformation', 5)
('tests', 12)
('increased', 40)
('rna', 28)
('detoxify', 2)
('possible', 2)
('general population', 4)
('early', 12)
('boxes', 2)
('background', 2)
('world', 14)
('unique', 4)
('case-control study', 22)
('kras gene', 4)
('specific', 18)
('either', 2)
('a t', 21)
('methods', 6)
('people', 13)
('dose-dependent', 4)
('growth', 5)
('histology', 4)
('respect', 8)
('subtypes', 1)
('questionnaire', 8)
('matching', 4)
('disrupting', 1)
('affects', 4)
('fluids', 4)
('ct scan', 2)
('smokers lung', 4)
('tissue sample', 4)
('moderate', 14)
('gene expression', 2)
('participation', 4)
('measuring', 4)
('data analysis', 4)
('patient', 114)
('2b', 4)
('90\\%', 4)
('equivalent', 4)
('bp', 4)
('new mexico', 19)
('chest computed tomography', 2)
('southwest asia', 2)
('stage', 20)
('rare', 8)
('lung cancer susceptibility', 1)
('predisposition', 9)
('carcinogenesis', 4)
('dollars', 2)
('let-7 mirna', 2)
('dependence', 4)
('lung tissue', 8)
('tumor', 64)
('binding site', 2)
('tailed', 8)
('confidence interval', 8)
('4 groups', 4)
('subset', 2)
('presence', 9)
('blood samples', 4)
('negative', 2)
('united states', 2)
('appropriate', 8)
('lung', 134)
('geographic locations', 4)
('categorization', 4)
('additional', 6)
('nucleotide', 5)
('sequence', 30)
('low', 59)
('breast cancer', 1)
('cell line', 9)
('cancer genes', 1)
('lowered', 2)
('veterans hospital', 4)
('cells', 22)
('exposure history', 4)
('chi-square test', 4)
('vivo', 5)
('un', 241)
('cancers', 2)
('mature', 1)
('polymorphisms', 3)
('stages', 10)
('similar', 11)
('clear', 2)
('detailed', 4)
('histologically', 4)
('associated', 35)
('binding sites', 1)
('deaths', 1)
('al', 703)
('general', 8)
('single', 4)
('exist', 9)
('statistical significance', 4)
('hospitals', 4)
('risk factor', 6)
('genetic variation', 6)
('demographic variables', 4)
('gg', 24)
('poor outcome', 1)
('ng', 540)
('prism', 4)
('role', 5)
('details', 4)
('papers', 1)
('test', 48)
('case-control studies', 1)
('cellular transformation', 1)
('variation', 18)
('research nurse', 4)
('important', 16)
('pathways', 4)
('fisher', 4)
('friends', 4)
('native american', 10)
('exposure', 20)
('age', 62)
('diagnosis', 8)
('time', 4)
('questionnaires', 4)
('lung cancer', 110)


total: 650('limited', 4)
('alleles', 4)
('global', 11)
('independent study', 4)
('messenger rna', 1)
('four', 8)
('non-small cell lung cancer', 6)
('current', 6)
('asian', 14)
('edu', 12)
('primer', 24)
('primary problem', 2)
('lcss', 21)
('eligible', 4)
('graph', 30)
('tt', 45)
('sequence variations', 6)
('gene-environment interaction', 4)
('tk', 4)
('tg', 12)
('chemopreventive agents', 2)
('veterans', 12)
('risk factors', 4)
('applied', 4)
('pack year', 5)
('assay', 16)
('risk', 84)
('cellular', 7)
('difference', 8)
('exact', 4)
('micrornas', 1)
('condition', 12)
('lcs6', 96)
('entire', 12)
('lcs4', 4)
('respiratory', 4)
('lcs1', 6)
('pcr\\.', 4)
('smoking status', 8)
('lcs9', 4)
('large', 10)
('control population', 4)
('vector', 4)
('biological', 4)
('target site', 1)
('cell lines', 5)
('findings', 28)
('triplicate', 2)
('let-7a', 10)
('fold', 7)
('second', 5)
('cost', 2)
('carcinogen', 6)
('further', 15)
('estimated', 2)
('blue', 4)
('spouses', 4)
('abi', 8)
('sum', 4)
('selected', 4)
('asia', 24)
('cell', 56)
('forward primer', 4)
('nm', 10)
('3c', 4)
('new', 27)
('contrast', 2)
('cohorts', 8)
('reporter', 28)
('genotyping', 4)
('genes', 19)
('normal tissue', 9)
('let', 78)
('groups', 12)
('histological type', 4)
('change', 4)
('almost', 4)
('east asia', 2)
('healthy', 12)
('study', 74)
('larger', 4)
('oncogenesis', 2)
('lin-28', 2)
('controversy', 2)
('prior', 10)
('infrequently', 4)
('products', 4)
('diagnosed', 4)
('usually', 4)
('lung adenocarcinoma', 4)
('gene', 80)
('studies', 30)
('biomarkers', 1)
('fbs', 4)
('family', 10)
('africa', 12)
('seven', 8)
('names', 4)
('marker', 22)
('tumor sample', 8)
('genetic resource', 4)
('use', 57)
('dna', 40)
('\xe2\x80\x9ceuropean\xe2\x80\x9d', 4)
('scan', 4)
('two', 38)
('few', 1)
('mirna', 17)
('december', 4)
('panel', 2)
('gene regulation', 2)
('more', 12)
('0\\%', 18)
('females', 4)
('populations', 54)
('constructs', 4)
('known', 7)
('cases', 83)
('effort', 2)
('97', 14)
('high', 23)
('ma', 182)
('cancer patient', 4)
('utrs', 2)
('restriction site', 4)
('lung tumors', 2)
('papillary thyroid cancer', 1)
('example', 4)
('10\\%', 6)
('history', 22)
('control', 92)
('slitrk1', 1)
('dna primers', 4)
('lung tumor resections', 4)
('sample', 68)
('allele frequency', 9)
('action', 12)
('native', 12)
('pink', 2)
('information', 8)
('discussion', 2)
('damage', 4)
('regression', 8)
('1', 327)
('likelihood ratio', 4)
('numerous', 2)
('adjacent', 14)
('significance', 8)
('product', 10)
('143', 2)
('perkinelmer', 4)
('overall', 4)
('act', 63)
('variant', 157)
('confirmed', 4)
('collection', 6)
('polymerase', 4)
('blood', 16)
('snp', 112)
('data', 32)
('types', 6)
('overexpression', 2)
('lines', 5)
('purification', 12)
('cigarettes', 4)
('non-small cell', 6)
('green', 2)
('african', 10)
('volunteers', 4)
('smoking history', 10)
('restriction', 4)
('feedback', 4)
('insight', 2)
('susceptibility\\.', 1)
('years', 49)
('130', 2)
('committee', 8)
('genetic predisposition', 4)
('activating', 8)
('regions', 3)
('group', 20)
('pcr', 30)
('mirna binding', 4)
('fig', 32)
('orange', 2)
('derivative', 4)
('non-small', 6)
('4866', 4)
('non', 29)
('fourth', 4)
('males', 8)
('school', 4)
('number', 2)
('data base', 4)
('one', 40)
('day', 4)
('association', 26)
('february', 4)
('0\\.9', 14)
('name', 4)
('university', 16)
('level', 47)
('identified', 29)
('mrna', 2)
('gender', 8)
('involvement', 4)
('european', 14)
('side', 22)
('control group', 4)
('heavy', 4)
('median', 20)
('abnormal', 1)
('related', 23)
('frequency', 52)
('binding sites', 1)
('year', 65)
('laboratory', 4)
('penicillin', 4)
('kras', 163)
('rt', 158)
('less frequent', 8)
('increase', 51)
('participants', 4)
('investigation', 4)
('messenger', 1)
('newly', 4)
('dysfunction', 1)
('cause', 12)
('red', 90)
('million', 2)
('regulators', 2)
('point mutation', 1)
('members', 8)
('seventy', 4)
('genotype', 12)
('interaction', 8)
('g', 1244)
('persons', 4)
('cell culture', 4)
('americas', 2)
('adjustment', 4)
('american', 10)
('smokers', 52)
('repeats', 2)
('first', 8)
('nhe', 4)
('control sample', 4)
('variables', 12)
('primary', 8)
('odds ratio', 4)
('construct', 8)
('wild-type', 30)
('quality', 4)
('size', 14)
('genetic cancer', 4)
('ten', 26)
('introduction', 1)
('leading', 1)
('logistic regression', 8)
('codons', 4)
('1a', 10)
('regulation', 18)
('1b', 10)
('siberia', 2)
('let-7 microrna', 1)
('nsclc', 108)
('molecular', 8)
('scans', 2)
('lipofectamine', 4)
('programs', 2)
('continuous', 4)
('small cell lung cancer', 10)
('untranslated regions', 1)
('rtpcr', 8)
('western', 2)
('chromosomes', 18)
('genomic dna', 8)
('population', 100)
('12', 30)
('target', 5)
('isolation', 4)
('database', 8)
('grey', 2)
('project', 2)
('patients', 90)
('future', 4)
('lcs6\\.', 2)
('target gene', 3)
('result', 12)
('7a', 10)
('boston', 14)
('30\\%', 4)
('ras', 222)
('need', 4)
('sample description', 4)
('lsc6', 4)
('current smoker', 2)
('mechanism', 8)
('note', 4)
('potential', 10)
('finding', 41)
('human population', 1)
('supplementary material', 2)
('normal', 20)
('tg\\+gg', 12)
('cigarette', 12)
('eight', 12)
('significant', 17)
('subset', 2)
('segment', 4)
('cancer genes', 1)
('geographic', 12)
('informed consent', 4)
('later', 2)
('disease', 6)
('first step', 2)
('natural selection', 1)
('dna repair gene', 2)
('cloning vector', 4)
('oncogenes', 3)
('geographic population', 8)
('kits', 4)
('unconditional', 8)
('hospital patients', 4)
('availability', 4)
('geography', 2)
('impact', 16)
('access', 4)
('smoking cessation', 6)
('untranslated', 1)
('controls', 48)
('only', 30)
('screening', 5)
('local', 8)
('dominant', 4)
('\\<3', 4)
('public health', 4)
('mgh', 12)
('lele', 203)
('single nucleotide polymorphisms', 1)
('dna polymerase', 4)
('negative', 2)
('tuberculosis', 4)
('3b', 4)
('2', 237)
('cardiothoracic', 4)
('c\\.i\\.\\=', 1)
('tumors', 34)
('nras', 12)
('genetic association', 4)
('common', 4)
('dna purification', 4)
('cancer risk', 24)
('europe', 16)
('bars', 2)
('set', 6)
('low frequency', 8)
('reference', 8)
('south central asia', 2)
('testing', 2)
('sex', 4)
('individual', 10)
('cloning', 8)
('genomic', 8)
('surgery', 4)
('\\/italic', 34)
('subject', 4)
('oncogene', 8)
('evaluation', 4)
('subsequent', 4)
('kit oncogene', 1)
('missing', 4)
('sites', 11)
('promega', 8)
('3', 262)
('un', 241)
('identification', 2)
('previous diagnosis', 4)
('approach', 4)
('lung ct', 2)
('available', 14)
('ends', 8)
('complementary', 16)
('snps', 32)
('fig\\.', 24)
('hypothesis', 14)
('extent', 4)
('molecular markers', 4)
('reaction', 2)
('1\\.1\\\xe2\\\x80\\\x931\\.7', 4)
('sputum', 4)
('region', 3)
('expense', 2)
('expression', 49)
('pack years', 5)
('ci', 210)
('luciferase activity', 6)
('cancer', 154)
('demographic', 8)
('let-7', 74)
('codon', 4)
('mutations', 15)
('case control', 4)
('dna repair pathway', 2)
('sequences', 4)
('dependent', 14)
('table', 40)
('a549', 18)
('age groups', 4)
('healthy adult', 4)
('described', 12)
('fre', 101)
('addition', 7)
('west', 8)
('three', 4)
('strategy', 2)
('genetic', 24)
('fluctuation', 2)
('life', 4)
('retrospective', 4)
('24 hours', 4)
('lcs', 137)
('representative', 2)
('smoking', 64)
('evidence', 3)
('case', 118)
('stage i', 4)
('caucasians', 4)
('frozen', 8)
('pgl3', 8)
('ongoing', 8)
('unreported', 4)
('error', 2)
('loop', 4)
('pack', 47)
('poor prognosis', 5)
('ct scans', 2)
('induced', 4)
('prevalence', 8)
('resident', 4)
('cell growth', 4)
('binding', 10)
('site', 33)
('very low', 2)
('tissue', 47)
('statistical analysis', 4)
('dual', 14)
('lymphoblastoid cell line', 4)
('ethnicity', 4)
('increased', 40)
('cohort', 36)
('different', 8)
('immunosuppression', 4)
('descent', 4)
('longitudinal studies', 4)
('same', 12)
('chest x-ray', 2)
('several', 5)
('higher', 13)
('independent', 6)
('in vivo', 5)
('http', 8)
('effect', 12)
('kit', 17)
('topo', 4)
('cessation', 6)
('levels', 39)
('i-', 8)
('purpose', 2)
('meta-analysis', 2)
('recent', 10)
('lower', 22)
('0\\.5\\\xe2\\\x80\\\x931\\.9', 2)
('confidence intervals', 4)
('vs\\.', 12)
('i', 4692)
('smoker', 58)
('analysis', 26)
('person', 8)
('squamous', 4)
('model', 12)
('paradigm', 4)
('epidemiological study', 4)
('less', 20)
('adjusted', 12)
('stored', 4)
('lymphoblastoid', 4)
('human', 22)
('study population', 12)
('alternative', 2)
('ng', 540)
('luciferase', 40)
('\\>', 68)
('\\?', 86)
('\\=', 36)
('mirnas', 7)
('location', 6)
('\\!', 4)
('lymphocytes', 4)
('allele', 199)
('extensive', 4)
('transformation', 5)
('\\(', 356)
('\\)', 356)
('pfuturbo', 4)
('tests', 12)
('microrna', 2)
('rna', 28)
('detoxify', 2)
('possible', 2)
('general population', 4)
('early', 12)
('boxes', 2)
('background', 2)
('world', 14)
('unique', 4)
('case-control study', 22)
('kras gene', 4)
('\\~', 4)
('specific', 18)
('either', 2)
('or\\=2\\.3', 4)
('a t', 21)
('methods', 6)
('people', 13)
('dose-dependent', 4)
('ct', 222)
('growth', 5)
('histology', 4)
('respect', 8)
('subtypes', 1)
('questionnaire', 8)
('rs712', 4)
('matching', 4)
('disrupting', 1)
('affects', 4)
('fluids', 4)
('ct scan', 2)
('smokers lung', 4)
('streptomycin', 4)
('tissue sample', 4)
('moderate', 14)
('gene expression', 2)
('participation', 4)
('measuring', 4)
('data analysis', 4)
('patient', 114)
('2b', 4)
('90\\%', 4)
('0\\.99', 2)
('equivalent', 4)
('bp', 4)
('new mexico', 19)
('chest computed tomography', 2)
('southwest asia', 2)
('stage', 20)
('rare', 8)
('lung cancer susceptibility', 1)
('predisposition', 9)
('carcinogenesis', 4)
('dollars', 2)
('let-7 mirna', 2)
('dependence', 4)
('lung tissue', 8)
('studied\\.', 1)
('tumor', 64)
('binding site', 2)
('tailed', 8)
('confidence interval', 8)
('4 groups', 4)
('or', 621)
('repair', 4)
('presence', 9)
('blood samples', 4)
('locus', 2)
('united states', 2)
('non-blood-related', 4)
('appropriate', 8)
('lung', 134)
('geographic locations', 4)
('cells\\.', 2)
('descriptions', 8)
('categorization', 4)
('utr\\.', 4)
('additional', 6)
('nucleotide', 5)
('sequence', 30)
('low', 59)
('breast cancer', 1)
('1\\.0', 18)
('\xe2\x80\x9chigh-risk\xe2\x80\x9d', 2)
('cell line', 9)
('lowered', 2)
('line', 37)
('veterans hospital', 4)
('cells', 22)
('exposure history', 4)
('rnas', 11)
('chi-square test', 4)
('vivo', 5)
('utr', 82)
('genetic markers', 1)
('cancers', 2)
('mature', 1)
('polymorphisms', 3)
('stages', 10)
('similar', 11)
('clear', 2)
('detailed', 4)
('histologically', 4)
('associated', 35)
('base pairs', 4)
('deaths', 1)
('al', 703)
('general', 8)
('single', 4)
('exist', 9)
('statistical significance', 4)
('hospitals', 4)
('risk factor', 6)
('mrnas', 2)
('genetic variation', 6)
('demographic variables', 4)
('gg', 24)
('poor outcome', 1)
('40', 19)
('41', 14)
('prism', 4)
('role', 5)
('details', 4)
('papers', 1)
('test', 48)
('1\\.1\\\xe2\\\x80\\\x934\\.6', 7)
('case-control studies', 1)
('cellular transformation', 1)
('variation', 18)
('research nurse', 4)
('important', 16)
('pathways', 4)
('fisher', 4)
('friends', 4)
('native american', 10)
('exposure', 20)
('pack\\-years\\.', 4)
('elcap', 2)
('age', 62)
('diagnosis', 8)
('time', 4)
('questionnaires', 4)
('lung cancer', 110)
